Inhibition of DNA replication of human papillomavirus by using zinc finger-single-chain FokI dimer hybrid

Takashi Mino, Tomoaki Mori, Yasuhiro Aoyama, Takashi Sera

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Previously, we reported that an artificial zinc-finger protein (AZP)-staphylococcal nuclease (SNase) hybrid (designated AZP-SNase) inhibited DNA replication of human papillomavirus type 18 (HPV-18) in mammalian cells by binding to and cleaving a specific HPV-18 ori plasmid. Although the AZP-SNase did not show any side effects under the experimental conditions, the SNase is potentially able to cleave RNA as well as DNA. In the present study, to make AZP hybrid nucleases that cleave only viral DNA, we switched the SNase moiety in the AZP-SNase to the single-chain FokI dimer (scFokI) that we had developed previously. We demonstrated that transfection with a plasmid expressing the resulting hybrid nuclease (designated AZP-scFokI) inhibited HPV-18 DNA replication in transient replication assays using mammalian cells more efficiently than AZP-SNase. Then, by linker-mediated PCR analysis, we confirmed that AZP-scFokI cleaved an HPV-18 ori plasmid around its binding site in mammalian cells. Finally, a modified MTT assay revealed that AZP-scFokI did not show any significant cytotoxicity. Thus, the newly developed AZP-scFokI hybrid is expected to serve as a novel antiviral reagent for the neutralization of human DNA viruses with less fewer potential side effects.

Original languageEnglish
Pages (from-to)731-737
Number of pages7
JournalMolecular Biotechnology
Volume56
Issue number8
DOIs
Publication statusPublished - 2014

Fingerprint

Zinc Fingers
DNA Replication
Dimers
Micrococcal Nuclease
Zinc
DNA
Proteins
Human papillomavirus 18
Plasmids
Cells
Assays
DNA Viruses
Viral DNA
Binding sites
Cytotoxicity
RNA
Viruses
Antiviral Agents
Transfection
Binding Sites

Keywords

  • Antiviral therapy
  • Artificial zinc-finger protein
  • DNA cleavage
  • Human DNA virus
  • Human papillomavirus
  • Hybrid nuclease
  • Single-chain FokI dimer

ASJC Scopus subject areas

  • Molecular Biology
  • Bioengineering
  • Applied Microbiology and Biotechnology
  • Biochemistry
  • Biotechnology
  • Medicine(all)

Cite this

Inhibition of DNA replication of human papillomavirus by using zinc finger-single-chain FokI dimer hybrid. / Mino, Takashi; Mori, Tomoaki; Aoyama, Yasuhiro; Sera, Takashi.

In: Molecular Biotechnology, Vol. 56, No. 8, 2014, p. 731-737.

Research output: Contribution to journalArticle

@article{a3a23468274b4b8eb8001deb468d4349,
title = "Inhibition of DNA replication of human papillomavirus by using zinc finger-single-chain FokI dimer hybrid",
abstract = "Previously, we reported that an artificial zinc-finger protein (AZP)-staphylococcal nuclease (SNase) hybrid (designated AZP-SNase) inhibited DNA replication of human papillomavirus type 18 (HPV-18) in mammalian cells by binding to and cleaving a specific HPV-18 ori plasmid. Although the AZP-SNase did not show any side effects under the experimental conditions, the SNase is potentially able to cleave RNA as well as DNA. In the present study, to make AZP hybrid nucleases that cleave only viral DNA, we switched the SNase moiety in the AZP-SNase to the single-chain FokI dimer (scFokI) that we had developed previously. We demonstrated that transfection with a plasmid expressing the resulting hybrid nuclease (designated AZP-scFokI) inhibited HPV-18 DNA replication in transient replication assays using mammalian cells more efficiently than AZP-SNase. Then, by linker-mediated PCR analysis, we confirmed that AZP-scFokI cleaved an HPV-18 ori plasmid around its binding site in mammalian cells. Finally, a modified MTT assay revealed that AZP-scFokI did not show any significant cytotoxicity. Thus, the newly developed AZP-scFokI hybrid is expected to serve as a novel antiviral reagent for the neutralization of human DNA viruses with less fewer potential side effects.",
keywords = "Antiviral therapy, Artificial zinc-finger protein, DNA cleavage, Human DNA virus, Human papillomavirus, Hybrid nuclease, Single-chain FokI dimer",
author = "Takashi Mino and Tomoaki Mori and Yasuhiro Aoyama and Takashi Sera",
year = "2014",
doi = "10.1007/s12033-014-9751-3",
language = "English",
volume = "56",
pages = "731--737",
journal = "Molecular Biotechnology",
issn = "1073-6085",
publisher = "Humana Press",
number = "8",

}

TY - JOUR

T1 - Inhibition of DNA replication of human papillomavirus by using zinc finger-single-chain FokI dimer hybrid

AU - Mino, Takashi

AU - Mori, Tomoaki

AU - Aoyama, Yasuhiro

AU - Sera, Takashi

PY - 2014

Y1 - 2014

N2 - Previously, we reported that an artificial zinc-finger protein (AZP)-staphylococcal nuclease (SNase) hybrid (designated AZP-SNase) inhibited DNA replication of human papillomavirus type 18 (HPV-18) in mammalian cells by binding to and cleaving a specific HPV-18 ori plasmid. Although the AZP-SNase did not show any side effects under the experimental conditions, the SNase is potentially able to cleave RNA as well as DNA. In the present study, to make AZP hybrid nucleases that cleave only viral DNA, we switched the SNase moiety in the AZP-SNase to the single-chain FokI dimer (scFokI) that we had developed previously. We demonstrated that transfection with a plasmid expressing the resulting hybrid nuclease (designated AZP-scFokI) inhibited HPV-18 DNA replication in transient replication assays using mammalian cells more efficiently than AZP-SNase. Then, by linker-mediated PCR analysis, we confirmed that AZP-scFokI cleaved an HPV-18 ori plasmid around its binding site in mammalian cells. Finally, a modified MTT assay revealed that AZP-scFokI did not show any significant cytotoxicity. Thus, the newly developed AZP-scFokI hybrid is expected to serve as a novel antiviral reagent for the neutralization of human DNA viruses with less fewer potential side effects.

AB - Previously, we reported that an artificial zinc-finger protein (AZP)-staphylococcal nuclease (SNase) hybrid (designated AZP-SNase) inhibited DNA replication of human papillomavirus type 18 (HPV-18) in mammalian cells by binding to and cleaving a specific HPV-18 ori plasmid. Although the AZP-SNase did not show any side effects under the experimental conditions, the SNase is potentially able to cleave RNA as well as DNA. In the present study, to make AZP hybrid nucleases that cleave only viral DNA, we switched the SNase moiety in the AZP-SNase to the single-chain FokI dimer (scFokI) that we had developed previously. We demonstrated that transfection with a plasmid expressing the resulting hybrid nuclease (designated AZP-scFokI) inhibited HPV-18 DNA replication in transient replication assays using mammalian cells more efficiently than AZP-SNase. Then, by linker-mediated PCR analysis, we confirmed that AZP-scFokI cleaved an HPV-18 ori plasmid around its binding site in mammalian cells. Finally, a modified MTT assay revealed that AZP-scFokI did not show any significant cytotoxicity. Thus, the newly developed AZP-scFokI hybrid is expected to serve as a novel antiviral reagent for the neutralization of human DNA viruses with less fewer potential side effects.

KW - Antiviral therapy

KW - Artificial zinc-finger protein

KW - DNA cleavage

KW - Human DNA virus

KW - Human papillomavirus

KW - Hybrid nuclease

KW - Single-chain FokI dimer

UR - http://www.scopus.com/inward/record.url?scp=84904855034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904855034&partnerID=8YFLogxK

U2 - 10.1007/s12033-014-9751-3

DO - 10.1007/s12033-014-9751-3

M3 - Article

VL - 56

SP - 731

EP - 737

JO - Molecular Biotechnology

JF - Molecular Biotechnology

SN - 1073-6085

IS - 8

ER -